Highlights DexCom, Inc.

Equities

DXCM

US2521311074

Market Closed - Nasdaq Other stock markets 01:30:01 01/06/2024 am IST			5-day change	1st Jan Change
118.8 ^USD	+0.32%		-6.74%	-4.28%

30/05	Redburn Atlantic Initiates DexCom With Neutral Rating, $130 Price Target	MT
24/05	Declaration of Voting Results by DexCom, Inc	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio Conscious Announces Strategic Api Integration with Dexcom That Will Elevate the Current Level of Care for Diabetes Patients in Clinical Settings	16/05	CI
Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology	30/04	CI
Wall Street: the worst week of 2024 is followed by the best	27/04	CF
Dexcom's profit beats estimates on strong glucose monitor demand	26/04	RE
DexCom, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04	CI
DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours	26/04	MT
Earnings Flash (DXCM) DEXCOM Posts Q1 EPS $0.32, vs. Street Est of $0.27	26/04	MT
Earnings Flash (DXCM) DEXCOM Posts Q1 Revenue $921M, vs. Street Est of $910.9M	26/04	MT
DexCom, Inc. Provides Earnings Guidance for the Year 2024	26/04	CI
MD Revolution Partners with Dexcom to Integrate Continuous Glucose Monitoring Systems with Its Remote Care Management Platform	10/04	CI
DexCom is still in the running	07/03
DexCom Shares Rise After Prescription-Free Glucose Biosensor Wins FDA Clearance	06/03	MT
US FDA clears use of first over-the-counter continuous glucose monitor	06/03	RE
DexCom Says Prescription-Free Glucose Biosensor Wins FDA Clearance	06/03	MT
US FDA clears use of first over-the-counter continuous glucose monitor	06/03	RE
DexCom, Inc. Announces the FDA Clears Stelo by Dexcom ? the First Glucose Biosensor	06/03	CI
DexCom, Inc. Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes with New Data at ATTD	05/03	CI
DexCom, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	09/02	CI
Dexcom beats profit estimates on strong demand for glucose monitors	09/02	RE
Dexcom Q4 Earnings, Revenue Increase; Sets 2024 Outlook	09/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

DexCom is still in the running

March 07, 2024 at 03:19 pm IST